News The full list of Quebec restaurants that won a Michelin Star in 2025 It's official: Here is the complete list of the first-ever Michelin-starred restaurants in Quebec.

Foresters Financial delivers higher dividends and increased interest rate, showcasing strong financial performance ...

In addition, the event will highlight M6P's S1S3 co-expression platform technology, designed to enhance mannose 6-phosphate (M6P) content on lysosomal enzymes to increase lysosomal targeting to ...

In addition, the event will highlight M6P's S1S3 co-expression platform technology, designed to enhance mannose 6-phosphate (M6P) content on lysosomal enzymes to increase lysosomal targeting to ...

University of Toronto researchers used machine learning to create nano-architected materials with the strength of carbon steel and the lightness of Styrofoam. Optimized nanolattices doubled the ...

Sanofi has developed a simpler way to create site-specific antibody-to-mannose-6-phosphate (M6P) conjugates that eliminates the need for enzyme remodeling. This more straightforward method makes ...

See the latest McPhy Energy SA stock price (M6P:XMUN), related news, valuation, dividends and more to help you make your investing decisions.

Reenie Perkovic, Registered Psychotherapist (Qualifying), Toronto, ON, M6P, (416) 966-5123, I’m Reenie (she/they) and I’m a queer therapist who values the importance of lived experiences and ...

Jesse Lawther, Registered Psychotherapist (Qualifying), Toronto, ON, M6P, (437) 747-0903, I work with queer people who are in the midst of change; grieving what once was, what could have been, and ...

In five poster presentations, including two Contemporary Forum presentations, M6P Therapeutics’ researchers report preclinical efficacy results for LSDs, including Gaucher disease and Pompe disease.

Patients with early-onset lysosomal storage diseases are ideal candidates for prenatal therapy because organ damage starts in utero. We report the safety and efficacy results of in utero enzyme-rep ...

M6P Therapeutics announced a poster presentation at the 29th Annual Congress of the European Society of Gene and Cell Therapy (ESGCT) 2022.